Metoclopramide Tablets Recalled for Presence of Foreign Tablets
Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP 10 mg due to the presence of foreign tablets or capsules in the product. The affected lot is distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is FDA Class II and involves a prescription drug with a manufacturing defect (foreign tablets/capsules in the product) that could result in serious patient harm. The presence of unidentified substances in a medication creates significant risk of adverse effects.
Plain-English summary
Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP 10 mg because foreign tablets or capsules have been found in the product. The recalled product is a prescription-only medication supplied in 100-count bottles.
The affected lot is Lot# 5420094 with an expiration date of 09/30/2027. Approximately 36,612 cartons have been distributed nationwide in the United States.
Consumers who have purchased this medication should not take it and should contact their pharmacy or healthcare provider. The presence of foreign tablets or capsules in the medication creates a safety risk, as patients may ingest unidentified substances instead of or in addition to their prescribed metoclopramide dose.
The recalled product
- Product
- METOCLOPRAMIDE (METOCLOPRAMIDE)
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Oral Tablet
- Hazard
- foreign-contamination
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 5420094
- Exp 09/30/2027
UPCs (2)
- 0300932203013
- 0300932204010
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOCLOPRAMIDE
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22